Chardan’s 9th Annual Genetic Medicines Conference brought together 70+ companies across the genetic medicines landscape. The conference featured nearly 20 panels covering topics such as:

• The Genetic Medicines Investment Thesis - What is driving capital today?
• Applications of Lessons Learned in Vector Gene Therapy
• Latest in RNA Editing (ADAR)
• The China Perspective

To access replays of the panel sessions or read summary research notes, please reach out to info@chardan.com